Skip to main content
SpringerLink
Log in

Managing acute renal failure in patients with acute decompensated heart failure: The cardiorenal syndrome

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

In patients with acute decompensated heart failure, worsening renal function during conventional decongestive therapy (cardiorenal syndrome) affects prognosis and the initiation of therapies with known benefit in chronic heart failure. Potential strategies for decongestion in patients who develop cardiorenal syndrome include invasive hemodynamic monitoring to guide therapy, use of continuous diuretic infusions, ultrafiltration, or novel therapy with adenosine or vasopressin receptor antagonists. Clinical trials by the National Heart, Lung, and Blood Institute’s Heart Failure Network are currently underway to validate such therapies in patients with acute decompensated heart failure with worsening renal function and to establish novel biomarkers for the early identification of patients who develop cardiorenal syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Lloyd-Jones D, Adams R, Carnethon M, et al.: Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119: e21–e181.

    Article  PubMed  Google Scholar 

  2. Hillege H, Girbes AR, de Kam P, et al.: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000, 102:203–210.

    PubMed  CAS  Google Scholar 

  3. Dries D, Exner D, Domanski M, et al.: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000, 35:681–689.

    Article  PubMed  CAS  Google Scholar 

  4. Heywood J, Fonarow G, Costanzo M, et al.: High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE Database. J Card Fail 2007, 13:422–430.

    Article  PubMed  Google Scholar 

  5. Yancy C, Lopatin M, Stevenson LW, et al.: Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006, 47:76–84.

    Article  PubMed  Google Scholar 

  6. Fonarow G, Adams KF, Abraham W, et al.: Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293:572–580.

    Article  PubMed  CAS  Google Scholar 

  7. Fillipatos G, Rossi J, Lloyd-Jones D, et al.: Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail 2007, 13:360–364.

    Article  Google Scholar 

  8. Goldberg R, Ismailov R, Patlolla V, et al.: Therapies for acute heart failure in patients with reduced kidney function: a community-based perspective. Am J Kidney Dis 2008, 51:594–602.

    Article  PubMed  Google Scholar 

  9. Smith G, Vaccarino V, Kosiborod M, et al.: Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003, 9:13–25.

    Article  PubMed  CAS  Google Scholar 

  10. Gottlieb S, Abraham W, Butler J, et al.: The prognostic importance of different definitions of worsening renal failure in congestive heart failure. J Card Fail 2002, 8:136–141.

    Article  PubMed  Google Scholar 

  11. Logeart D, Tabet J-Y, Hittinger L et al.: Transient worsening of renal function during hospitalization for acute heart failure alters outcomes. Int J Cardiol 2008, 127:228–232.

    Article  PubMed  Google Scholar 

  12. Forman D, Butler J, Wang Y, et al.: Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004, 43:61–67.

    Article  PubMed  Google Scholar 

  13. Butler J, Forman D, Abraham W, et al.: Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004, 147:331–338.

    Article  PubMed  Google Scholar 

  14. Ronco C, Haapio M, House A, et al.: Cardiorenal syndrome. J Am Coll Cardiol 2008, 52:1527–1539.

    Article  PubMed  Google Scholar 

  15. Nohria A, Hasselblad V, Stebbins A, et al.: Cardiorenal interactions insights from the ESCAPE trial. J Am Coll Cardiol 2008, 51:1268–1274.

    Article  PubMed  Google Scholar 

  16. Damman K, Navis G, Smilde T, et al.: Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 2007, 9:872–878.

    Article  PubMed  Google Scholar 

  17. Mullens W, Abrahams Z, Francis G, et al.: Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009, 53:589–596.

    Article  PubMed  Google Scholar 

  18. Mullens W, Abrahams Z, Skouri H, et al.: Elevated intraabdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 2008, 51:300–306.

    Article  PubMed  Google Scholar 

  19. Costanzo M, Johannes R, Pine M, et al.: The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database. Am Heart J 2007, 154:267–277.

    Article  PubMed  CAS  Google Scholar 

  20. Mullens W, Abrahams Z, Francis G, et al.: Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 2008, 52:200–207.

    Article  PubMed  CAS  Google Scholar 

  21. Sackner-Bernstein J, Kowalski M, Fox M, et al.: Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005, 293:1900–1905.

    Article  PubMed  CAS  Google Scholar 

  22. Sackner-Bernstein J, Skopicki H, Aaronson K: Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005, 111:1487–1491.

    Article  PubMed  CAS  Google Scholar 

  23. McCullough P: Contrast-induced acute kidney injury. J Am Coll Cardiol 2008, 51:1419–1428.

    Article  PubMed  Google Scholar 

  24. Peacock WF, Costanzo M, De Marco T, et al.: Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology 2009, 113:12–19.

    Article  PubMed  Google Scholar 

  25. Bongartz L, Jan Cramer M, Doevendans P, et al.: The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 2005, 26:11–17.

    Article  PubMed  Google Scholar 

  26. Kelly K: Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 2003, 14:1549–1558.

    Article  PubMed  CAS  Google Scholar 

  27. Jie K, Verhaar M, Jan Cramer M, et al.: Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol 2006, 291:932–944.

    Article  Google Scholar 

  28. Palazzuoli A, Silverberg D, Iovine F, et al.: Effects of erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome. Am Heart J 2007, 154:645e9–645e15.

    Article  Google Scholar 

  29. Brater D: Diuretic therapy. N Engl J Med 1998, 339:387–395.

    Article  PubMed  CAS  Google Scholar 

  30. Vasko M, Cartwright D, Knochel J, et al.: Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985, 102:314–318.

    PubMed  CAS  Google Scholar 

  31. Abdallah J, Schrier R, Edelstein C, et al.: Loop diuretic infusion increases thiazide-sensitive Na(+)/Cl(−)-cotransporter abundance: role of aldosterone. J Am Soc Nephrol 2001, 12:1335–1341.

    PubMed  CAS  Google Scholar 

  32. Lahav M, Regev A, Ra’anani P, et al.: Intermittent administration of furosemide versus continuous infusion preceded by a loading dose for congestive heart failure. Chest 1992, 102:725–731.

    Article  PubMed  CAS  Google Scholar 

  33. Dormans T, van Meyel JJ, Gerlag P, et al.: Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 1996, 28:376–382.

    Article  PubMed  CAS  Google Scholar 

  34. Salvador DR, Rey NR, Ramos GC, Punzalan FE: Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 2005, 20:CD003178.

    Google Scholar 

  35. Howard P, Dunn M: Aggressive diuresis for severe heart failure in the elderly. Chest 2001, 119:807–810.

    Article  PubMed  CAS  Google Scholar 

  36. Heart Failure Network: Available at http://www.hfnetwork.org. Accessed December 3, 2008.

  37. Allen L, Rogers J, Warnica J, et al.: High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization. J Card Fail 2008, 14:661–669.

    Article  PubMed  Google Scholar 

  38. Elkayam U, Ng, T, Hatamizadeh P, et al.: Renal vasodilatory action of dopamine in patients with heart failure: magnitude of effect and site of action. Circulation 2008, 117:200–205.

    Article  PubMed  CAS  Google Scholar 

  39. Ungar A, Fumagalli S, Marini M, et al.: Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med 2004, 32:1126–1129.

    Article  Google Scholar 

  40. Abraham WT, Adams KF, Fonarow GC, et al.: In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005, 46:57–64.

    Article  PubMed  Google Scholar 

  41. Iglesias J, DePalma L, Hom D, et al.: Predictors of mortality in adult patients with congestive heart failure receiving nesiritide-retrospective analysis showing a potential adverse interaction between neseritide [sic] and acute renal dysfunction. Nephrol Dial Transplant 2008, 23:144–153.

    Article  PubMed  CAS  Google Scholar 

  42. Witteles R, Kao D, Christopherson D, et al.: Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction. J Am Coll Cardiol 2007, 50:1835–1840.

    Article  PubMed  CAS  Google Scholar 

  43. Yancy C, Krum H, Massie B, et al.: Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the second follow-up serial infusions of nesiritide (FUSION-II) trial. Circ Heart Fail 2008, 1:9–16.

    Article  CAS  Google Scholar 

  44. Riter H, Redfield M, Burnett J, et al.: Nonhypotensive lowdose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol 2006, 47:2334–2335.

    Article  PubMed  CAS  Google Scholar 

  45. Armstrong P, Rouleau J: A Canadian context for the acute study of clinical effectiveness of nesiritide and decompensated heart failure (ASCEND-HF) trial. Can J Cardiol 2008, 24:30B–32B.

    PubMed  CAS  Google Scholar 

  46. Wertman B, Gura V, Schwarz E: Ultrafiltration for the management of acute decompensated heart failure. J Card Fail 2008, 14:754–759.

    Article  PubMed  Google Scholar 

  47. Agostoni P, Marenzi G, Lauri G, et al.: Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994, 96:191–199.

    Article  PubMed  CAS  Google Scholar 

  48. Costanzo M, Guglin M, Saltzberg M, et al.: Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49:675–683.

    Article  PubMed  CAS  Google Scholar 

  49. Konstam M, Gheorghiade M, Burnett J, et al.: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 2007, 297:1319–1331.

    Article  PubMed  CAS  Google Scholar 

  50. Goldsmith S: Treatment options for hyponatremia in heart failure. Heart Fail Rev 2009, 14:87–88.

    Article  Google Scholar 

  51. Kriz W: Adenosine and ATP: traffic regulators in the kidney. J Clin Invest 2004, 114:611–613.

    PubMed  CAS  Google Scholar 

  52. Vallon V, Muhlbauer B, Osswald H: Adenosine and kidney function. Physiol Rev 2006, 86:901–940.

    Article  PubMed  CAS  Google Scholar 

  53. Givertz M, Massie B, Fields T, et al.: The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 2007, 50:1551–1560.

    Article  PubMed  CAS  Google Scholar 

  54. Cotter G, Dittrich H, Weatherley B, et al.: The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 2008, 14:631–640.

    Article  PubMed  CAS  Google Scholar 

  55. Merck.com: Rolofylline did not demonstrate efficacy for acute heart failure in clinical trial. Available at http://www.merck.com/newsroom/press_releases/research_and_development/2009_0605.html. Accessed June 19, 2009.

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA, 02115, USA

    Michael M. Givertz

Authors
  1. Ravi V. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael M. Givertz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael M. Givertz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, R.V., Givertz, M.M. Managing acute renal failure in patients with acute decompensated heart failure: The cardiorenal syndrome. Curr Heart Fail Rep 6, 176–181 (2009). https://doi.org/10.1007/s11897-009-0025-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-009-0025-5

Keywords

Search

Navigation